05.10.2018 22:45:00

Global Hemophilia Market and Competitive Landscape 2014-2018 & 2023

DUBLIN, Oct. 5, 2018 /PRNewswire/ --

The "Global Hemophilia Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

The latest research Global Hemophilia Market and Competitive Landscape - 2018, provides comprehensive insights into Hemophilia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Hemophilia market size and drug sales. This research also provides insights into Hemophilia epidemiology and late stage pipeline.

Research Scope:

  • Hemophilia pipeline: Find out the drugs in clinical trials for Hemophilia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Hemophilia epidemiology: Find out the prevalence of Hemophilia by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Hemophilia products: Identify key products marketed and prescribed for Hemophilia by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Hemophilia market size: Find out the market size for Hemophilia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Hemophilia drug sales: Find out the sales of Hemophilia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Hemophilia drugs sales forecast: Sales forecast for Hemophilia drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Hemophilia market share analysis: Find out the market shares of Hemophilia drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

  • Evaluate commercial market opportunities for Hemophilia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Hemophilia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Hemophilia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Hemophilia: Disease Overview
1.1. Hemophilia Symptoms
1.2. Hemophilia Etiology
1.3. Hemophilia Diagnosis
1.4. Hemophilia Treatment Options

2. Hemophilia Pipeline Insights
2.1. Hemophilia Phase 3 Clinical Trials
2.2. Hemophilia Phase 2 Clinical Trials
2.3. Hemophilia Phase 1 Clinical Trials

3. Hemophilia Epidemiology Analysis

4. US Hemophilia Market Insights
4.1. Marketed Products for Hemophilia in US
4.2. US Hemophilia Market Size & Forecast
4.3. US Hemophilia Product Sales Forecast
4.4. US Hemophilia Market Share Analysis

5. Germany Hemophilia Market Insights
5.1. Marketed Products for Hemophilia in Germany
5.2. Germany Hemophilia Market Size & Forecast
5.3. Germany Hemophilia Product Sales Forecast
5.4. Germany Hemophilia Market Share Analysis

6. France Hemophilia Market Insights
6.1. Marketed Products for Hemophilia in France
6.2. France Hemophilia Market Size & Forecast
6.3. France Hemophilia Product Sales Forecast
6.4. France Hemophilia Market Share Analysis

7. Italy Hemophilia Market Insights
7.1. Marketed Products for Hemophilia in Italy
7.2. Italy Hemophilia Market Size & Forecast
7.3. Italy Hemophilia Product Sales Forecast
7.4. Italy Hemophilia Market Share Analysis

8. Spain Hemophilia Market Insights
8.1. Marketed Products for Hemophilia in Spain
8.2. Spain Hemophilia Market Size & Forecast
8.3. Spain Hemophilia Product Sales Forecast
8.4. Spain Hemophilia Market Share Analysis

9. UK Hemophilia Market Insights
9.1. Marketed Products for Hemophilia in UK
9.2. UK Hemophilia Market Size & Forecast
9.3. UK Hemophilia Product Sales Forecast
9.4. UK Hemophilia Market Share Analysis

10. Europe Hemophilia Market Insights
10.1. Europe Hemophilia Market Size & Forecast
10.2. Europe Hemophilia Product Sales Forecast
10.3. Europe Hemophilia Market Share Analysis

11. Japan Hemophilia Market Insights
11.1. Marketed Products for Hemophilia in Japan
11.2. Japan Hemophilia Market Size & Forecast
11.3. Japan Hemophilia Product Sales Forecast
11.4. Japan Hemophilia Market Share Analysis

12. Global Hemophilia Market Insights
12.1. Global Hemophilia Market Size & Forecast
12.2. Global Hemophilia Product Sales Forecast
12.3. Global Hemophilia Market Share Analysis

13. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/zn25hn/global_hemophilia?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-hemophilia-market-and-competitive-landscape-2014-2018--2023-300725246.html

SOURCE Research and Markets

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!